glp-1 overview PDB-101: Molecule of the Month: Receptor Agonists Evolution of GLP‐1 Receptor Agonists

Roughly 1 in 8 (12%) consumers have taken a GLP-1 drug , per KFF, and that share is likely to rise: 26% of US consumers plan to take a weight loss drug to achieve their 2025 New Year's resolution goals , per Tebra

Taken together it is apparent that clinicians have few tools with which to fight obesity and weight gain

But like any drug, GLP-1s wont produce the same effects in everyone

these are often temporary and may improve with time Seek immediate medical attention for signs of pancreatitis such as severe abdominal pain that may radiate to the back Inform your healthcare provider of all medications you take, as some drugs may interact with semaglutide